Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
about
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
P2860
Q38722948-18E1C96C-B1AF-42D8-A51E-8274BBF23D45Q38726616-DCBCCA5A-B578-4432-8E03-9E85A776F855Q38729384-84E461B1-4D71-4B92-8F6C-CAA7E19955DFQ38847914-C28DA30A-366A-4A98-9CEA-4ED9F788AD60Q38948699-68ED4861-57FD-491F-9571-BE9A1411512AQ39429946-20ACFE83-5205-48ED-AC1D-7074BF87CA33Q47131461-D3D25E4E-6449-45C7-A9D6-8FA4BDB02394Q57135103-44F5CA16-153F-4291-B67A-48662F249386
P2860
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@en
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@nl
type
label
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@en
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@nl
prefLabel
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@en
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@nl
P2093
P2860
P356
P1433
P1476
Open-label, randomized study o ...... mall-cell lung cancer (NSCLC).
@en
P2093
D M Behringer
J R Fischer
J von Pawel
M C Miller
P2860
P304
P356
10.1093/ANNONC/MDW290
P577
2016-08-08T00:00:00Z